Latest News
Weak dollar, foreign sales boost drugmakers
Boston Globe, The | 59 minutes ago
TRENTON, N.J.—Profits posted Wednesday by Pfizer Inc. and Wyeth show a common theme among pharmaceutical companies -- nearly all the growth they're seeing these days is overseas, driven by emerging markets and the weak dollar.... (more)
Merck and Schering-Plough prepare Vytorin letter
Boston Globe, The | 59 minutes ago
NEW YORK—Vytorin partners Merck & Co. and Schering-Plough Corp. have prepared a letter for physicians who might be concerned over recent study results that showed patients taking the cholesterol drug were at higher risk of dying from cancer.... (more)
Genzyme shares fall on more Myozyme delays
Boston Globe, The | 59 minutes ago
NEW YORK—Shares of Genzyme Corp. fell Wednesday after the company reported positive second-quarter financial results but said plans to increase production of its genetic disorder drug Myozyme could be further delayed, pending a regulatory review.... (more)
Genetics pioneer McKusick honored
Sun (Baltimore), The | 1 hour ago
Dr. Victor A. McKusick, a Johns Hopkins professor widely considered the father of medical genetics, has been awarded the prestigious Japan Prize in Medical Genetics and Genomics and the $470,000 that goes with it.... (more)
Free Preview - WSJ.com
Barron's | 1 hour 6 minutes ago
Biogen Idec (BIIB: Nasdaq) By Robert W. Baird ($71.28, July 23, 2008)... (more)
Durham to consider millions in incentives for Merck
News & Observer (Raleigh, N.C.), The | 1 hour 7 minutes ago
Comment on this story DURHAM -- The Durham County Board of Commissioners on Monday will consider giving drug company Merck $2 million in economic incentives to expand its Durham facility, adding 150 to 180 jobs.County staffers have recommended that the board approve the proposal. The board will hold a public hearing at 7 p.m. Monday at its chambers on the second floor of 200 E. Main St., and will then vote.Merck's expansion would bring a $300 million investment to the county and the Treyb...... (more)
Slowing the Growth of Health Care Costs
New England Journal of Medicine, The | 1 hour 12 minutes ago
Slowing the Growth of Health Care Costs... (more)
Amerigroup swings to loss as sales climb - MarketWatch
MarketWatch | 1 hour 12 minutes ago
LOS ANGELES (MarketWatch) -- Amerigroup Corp. posted a second-quarter loss Wednesday due to the settlement of outstanding qui tam civil litigation, but the health insurer's operating income came in well ahead of street views.... (more)
GlaxoSmithKline to break up research and development operations
Times (London), The | 1 hour 15 minutes ago
The world's second-largest pharmaceuticals group is to abandon its big-is-beautiful model and run its businesses more like small biotech outfits.... (more)
382 Stories |
RSS Feed
Sign up for FDLI SmartBrief
Latest Blog Postsview more
Tracking Pharmaceutical Stocks
Eye on FDA
Polarizing filter allows astronomers to see disks surrounding black holes
Science Blog
Toxic chemicals found in common scented laundry products, air fresheners
Science Blog
Commercially-bred Bees Responsible for Decline in Bee Population?
Science Blog
Job Listingsview more
- Assistant General Counsel (FDA Regulatory)
Astellas - Senior Corporate Attorney (Research & Development)
Astellas - Senior Counsel, Regulatory
American Red Cross - Corporate Lawyer - Regulatory and Compliance
Grifols Inc. - Assistant General Counsel (FDA Regulatory)
Astellas
Companies in the news
- AGA Medical
- Barr Pharmaceuticals Inc
- BioSante Pharmaceuticals, Inc.
- Boehringer Ingelheim
- EpiCept Corporation
- Galapagos NV
- GlaxoSmithKline plc
- Health Care
- Intuitive Surgical Inc
- Johnson & Johnson
- MediGene AG
- Novartis
- Omrix Biopharmaceuticals Ltd.
- Ranbaxy Laboratories
- South Bend
